Sumitomo Pharma Co (TSE:4506) Other Income (Expense) : 円0 Mil (TTM As of Mar. 2024)

View and export this data going back to 1949. Start your Free Trial

What is Sumitomo Pharma Co Other Income (Expense)?

Sumitomo Pharma Co's other income expense for the Sumitomo Pharma Co's pretax income for the three months ended in Mar. 2024 was 円0 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was 円0 Mil.

Sumitomo Pharma Co Other Income (Expense) Historical Data

The historical data trend for Sumitomo Pharma Co's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sumitomo Pharma Co Other Income (Expense) Chart

Sumitomo Pharma Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Income (Expense)

Get a 7-Day Free Trial

Sumitomo Pharma Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Income (Expense)	Get a 7-Day Free Trial															-	-	-	-	-

Sumitomo Pharma Co Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0 Mil.

Sumitomo Pharma Co (TSE:4506) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Sumitomo Pharma Co (TSE:4506) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sumitomo Pharma Co Ltd (TSE:4506) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

DNPUF:USA DPM:Germany

Address

6-8, Doshomachi 2-chome, Chuo-ku, Osaka, JPN, 541-0045

Website

https://www.sumitomo-pharma.com

Sumitomo Pharma Co Ltd is a specialty and generic drug manufacturing company. Sumitomo's vast majority of sales are generated in North America, followed by Japan. The company's core business is its pharmaceutical products business. The pharmaceutical business maintains a focus on a variety of areas, including cardiovascular/diabetes, psychiatry & neurology, and specialty areas. Sumitomo considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Sumitomo Pharma Co (TSE:4506) Headlines

No Headlines